1.Practice guidelines for managing extrahepatic biliary tract cancers
Hyung Sun KIM ; Mee Joo KANG ; Jingu KANG ; Kyubo KIM ; Bohyun KIM ; Seong-Hun KIM ; Soo Jin KIM ; Yong-Il KIM ; Joo Young KIM ; Jin Sil KIM ; Haeryoung KIM ; Hyo Jung KIM ; Ji Hae NAHM ; Won Suk PARK ; Eunkyu PARK ; Joo Kyung PARK ; Jin Myung PARK ; Byeong Jun SONG ; Yong Chan SHIN ; Keun Soo AHN ; Sang Myung WOO ; Jeong Il YU ; Changhoon YOO ; Kyoungbun LEE ; Dong Ho LEE ; Myung Ah LEE ; Seung Eun LEE ; Ik Jae LEE ; Huisong LEE ; Jung Ho IM ; Kee-Taek JANG ; Hye Young JANG ; Sun-Young JUN ; Hong Jae CHON ; Min Kyu JUNG ; Yong Eun CHUNG ; Jae Uk CHONG ; Eunae CHO ; Eui Kyu CHIE ; Sae Byeol CHOI ; Seo-Yeon CHOI ; Seong Ji CHOI ; Joon Young CHOI ; Hye-Jeong CHOI ; Seung-Mo HONG ; Ji Hyung HONG ; Tae Ho HONG ; Shin Hye HWANG ; In Gyu HWANG ; Joon Seong PARK
Annals of Hepato-Biliary-Pancreatic Surgery 2024;28(2):161-202
		                        		
		                        			 Background:
		                        			s/Aims: Reported incidence of extrahepatic bile duct cancer is higher in Asians than in Western populations. Korea, in particular, is one of the countries with the highest incidence rates of extrahepatic bile duct cancer in the world. Although research and innovative therapeutic modalities for extrahepatic bile duct cancer are emerging, clinical guidelines are currently unavailable in Korea. The Korean Society of Hepato-Biliary-Pancreatic Surgery in collaboration with related societies (Korean Pancreatic and Biliary Surgery Society, Korean Society of Abdominal Radiology, Korean Society of Medical Oncology, Korean Society of Radiation Oncology, Korean Society of Pathologists, and Korean Society of Nuclear Medicine) decided to establish clinical guideline for extrahepatic bile duct cancer in June 2021. 
		                        		
		                        			Methods:
		                        			Contents of the guidelines were developed through subgroup meetings for each key question and a preliminary draft was finalized through a Clinical Guidelines Committee workshop. 
		                        		
		                        			Results:
		                        			In November 2021, the finalized draft was presented for public scrutiny during a formal hearing. 
		                        		
		                        			Conclusions
		                        			The extrahepatic guideline committee believed that this guideline could be helpful in the treatment of patients. 
		                        		
		                        		
		                        		
		                        	
2.Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)
Nam Hoon KIM ; Juneyoung LEE ; Suk CHON ; Jae Myung YU ; In-Kyung JEONG ; Soo LIM ; Won Jun KIM ; Keeho SONG ; Ho Chan CHO ; Hea Min YU ; Kyoung-Ah KIM ; Sang Soo KIM ; Soon Hee LEE ; Chong Hwa KIM ; Soo Heon KWAK ; Yong‐ho LEE ; Choon Hee CHUNG ; Sihoon LEE ; Heung Yong JIN ; Jae Hyuk LEE ; Gwanpyo KOH ; Sang-Yong KIM ; Jaetaek KIM ; Ju Hee LEE ; Tae Nyun KIM ; Hyun Jeong JEON ; Ji Hyun LEE ; Jae-Han JEON ; Hye Jin YOO ; Hee Kyung KIM ; Hyeong-Kyu PARK ; Il Seong NAM-GOONG ; Seongbin HONG ; Chul Woo AHN ; Ji Hee YU ; Jong Heon PARK ; Keun-Gyu PARK ; Chan Ho PARK ; Kyong Hye JOUNG ; Ohk-Hyun RYU ; Keun Yong PARK ; Eun-Gyoung HONG ; Bong-Soo CHA ; Kyu Chang WON ; Yoon-Sok CHUNG ; Sin Gon KIM
Endocrinology and Metabolism 2024;39(5):722-731
		                        		
		                        			 Background:
		                        			Atherogenic dyslipidemia, which is frequently associated with type 2 diabetes (T2D) and insulin resistance, contributes to the development of vascular complications. Statin therapy is the primary approach to dyslipidemia management in T2D, however, the role of non-statin therapy remains unclear. Ezetimibe reduces cholesterol burden by inhibiting intestinal cholesterol absorption. Fibrates lower triglyceride levels and increase high-density lipoprotein cholesterol (HDL-C) levels via peroxisome proliferator- activated receptor alpha agonism. Therefore, when combined, these drugs effectively lower non-HDL-C levels. Despite this, few clinical trials have specifically targeted non-HDL-C, and the efficacy of triple combination therapies, including statins, ezetimibe, and fibrates, has yet to be determined. 
		                        		
		                        			Methods:
		                        			This is a multicenter, prospective, randomized, open-label, active-comparator controlled trial involving 3,958 eligible participants with T2D, cardiovascular risk factors, and elevated non-HDL-C (≥100 mg/dL). Participants, already on moderate-intensity statins, will be randomly assigned to either Ezefeno (ezetimibe/fenofibrate) addition or statin dose-escalation. The primary end point is the development of a composite of major adverse cardiovascular and diabetic microvascular events over 48 months. 
		                        		
		                        			Conclusion
		                        			This trial aims to assess whether combining statins, ezetimibe, and fenofibrate is as effective as, or possibly superior to, statin monotherapy intensification in lowering cardiovascular and microvascular disease risk for patients with T2D. This could propose a novel therapeutic approach for managing dyslipidemia in T2D. 
		                        		
		                        		
		                        		
		                        	
3.A Validation of the Korean Version of Ultra-Short Suicidal Ideation Scale
Kyung Seu YOON ; Eunkyung KIM ; Yong Chon PARK ; Daeho KIM ; Joonho CHOI ; Seon-Cheol PARK ; Il Bin KIM ; Yu Sang LEE
Journal of Korean Neuropsychiatric Association 2023;62(3):111-117
		                        		
		                        			 Objectives:
		                        			An accurate and easy-to-identify form is needed for the early evaluation of suicidal ideation in high-risk patients. Therefore, this study examined the validity and reliability of a Korean version of the Ultra-Short Suicidal Ideation Scale (K-USSIS). 
		                        		
		                        			Methods:
		                        			A total of 161 psychiatric university-affiliated general hospital patients completed the K-USSIS. The data were analyzed using correlation, internal consistency, and confirmatory factor analyses. 
		                        		
		                        			Results:
		                        			First, the scale had good internal consistency with a Cronbach’s α of 0.94. Second, the confirmatory factor analysis demonstrated that the single-factor model had a reasonable fit (comparative fit index=0.99, Tucker–Lewis index=0.98, standardized root mean squared residual=0.01, and root mean square error of approximation=0.10). Finally, the convergent validity analysis revealed a significant positive correlation with depression, anxiety, and hopelessness. 
		                        		
		                        			Conclusion
		                        			The findings suggest that the K-USSIS has good psychometric properties and can serve as a valuable tool for screening for suicidal ideation to ensure early intervention in Korean psychiatric patients. 	 
		                        		
		                        		
		                        		
		                        	
4.Multiple Dural Arteriovenous Fistulas Presenting as Pulsatile Tinnitus Treated with External Manual Compression.
Se Joon OH ; Yong Il CHON ; Soo Keun KONG ; Eui Kyung GOH
Journal of Audiology & Otology 2017;21(3):156-159
		                        		
		                        			
		                        			Dural arteriovenous fistula (DAVF) have been treated by transarterial or transvenous embolization, surgery, and radiosurgery. Besides these treatment options, the external compression technique is a non-invasive, low-cost form of treatment. This article reports that a 60-year-old man with DAVF between multiple arterial branches and transverse/sigmoid sinus was treated by repeated external manual compression method.
		                        		
		                        		
		                        		
		                        			Arteriovenous Fistula
		                        			;
		                        		
		                        			Central Nervous System Vascular Malformations*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Methods
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Radiosurgery
		                        			;
		                        		
		                        			Tinnitus*
		                        			
		                        		
		                        	
5.Multiple Dural Arteriovenous Fistulas Presenting as Pulsatile Tinnitus Treated with External Manual Compression.
Se Joon OH ; Yong Il CHON ; Soo Keun KONG ; Eui Kyung GOH
Journal of Audiology & Otology 2017;21(3):156-159
		                        		
		                        			
		                        			Dural arteriovenous fistula (DAVF) have been treated by transarterial or transvenous embolization, surgery, and radiosurgery. Besides these treatment options, the external compression technique is a non-invasive, low-cost form of treatment. This article reports that a 60-year-old man with DAVF between multiple arterial branches and transverse/sigmoid sinus was treated by repeated external manual compression method.
		                        		
		                        		
		                        		
		                        			Arteriovenous Fistula
		                        			;
		                        		
		                        			Central Nervous System Vascular Malformations*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Methods
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Radiosurgery
		                        			;
		                        		
		                        			Tinnitus*
		                        			
		                        		
		                        	
6.Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
Jung Yeon LEE ; Gyu Rak CHON ; Chin Kook RHEE ; Deog Kyeom KIM ; Hyoung Kyu YOON ; Jin Hwa LEE ; Kwang Ha YOO ; Sang Haak LEE ; Sang Yeub LEE ; Tae Eun KIM ; Tae Hyung KIM ; Yong Bum PARK ; Yong Il HWANG ; Young Sam KIM ; Ki Suck JUNG
Journal of Korean Medical Science 2016;31(4):553-560
		                        		
		                        			
		                        			The Korea Chronic Obstructive Pulmonary Disorders Subgroup Study Team (Korea COPD Subgroup Study team, KOCOSS) is a multicenter observational study that includes 956 patients (mean age 69.9 ± 7.8 years) who were enrolled from 45 tertiary and university-affiliated hospitals from December 2011 to October 2014. The initial evaluation for all patients included pulmonary function tests (PFT), 6-minute walk distance (6MWD), COPD Assessment Test (CAT), modified Medical Research Council (mMRC) dyspnea scale, and the COPD-specific version of St. George's Respiratory Questionnaire (SGRQ-C). Here, we report the comparison of baseline characteristics between patients with early- (Global Initiative for Chronic Obstructive Lung Disease [GOLD] stage I and II/groups A and B) and late-stage COPD (GOLD stage III and IV/groups C and D). Among all patients, the mean post-bronchodilator FEV1 was 55.8% ± 16.7% of the predicted value, and most of the patients were in GOLD stage II (520, 56.9%) and group B (399, 42.0%). The number of exacerbations during one year prior to the first visit was significantly lower in patients with early COPD (0.4 vs. 0.9/0.1 vs. 1.2), as were the CAT score (13.9 vs. 18.3/13.5 vs. 18.1), mMRC (1.4 vs. 2.0/1.3 vs.1.9), and SGRQ-C total score (30.4 vs. 42.9/29.1 vs. 42.6) compared to late-stage COPD (all P < 0.001). Common comorbidities among all patients were hypertension (323, 37.7%), diabetes mellitus (139, 14.8%), and depression (207, 23.6%). The data from patients with early COPD will provide important information towards early detection, proper initial management, and design of future studies.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Cohort Studies
		                        			;
		                        		
		                        			Comorbidity
		                        			;
		                        		
		                        			Depression/epidemiology
		                        			;
		                        		
		                        			Diabetes Mellitus/epidemiology
		                        			;
		                        		
		                        			Dyspnea/complications
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Forced Expiratory Volume
		                        			;
		                        		
		                        			Hospitals, University
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypertension/epidemiology
		                        			;
		                        		
		                        			Lung/physiopathology
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Pulmonary Disease, Chronic Obstructive/complications/*diagnosis/physiopathology
		                        			;
		                        		
		                        			Quality of Life
		                        			;
		                        		
		                        			Republic of Korea
		                        			;
		                        		
		                        			Respiratory Function Tests
		                        			;
		                        		
		                        			Severity of Illness Index
		                        			;
		                        		
		                        			Societies, Medical
		                        			;
		                        		
		                        			Surveys and Questionnaires
		                        			;
		                        		
		                        			Tertiary Care Centers
		                        			;
		                        		
		                        			Walk Test
		                        			
		                        		
		                        	
7.Safety and Efficacy of Modern Insulin Analogues.
Hye Jin YOO ; Keun Yong PARK ; Kang Seo PARK ; Kyu Jeung AHN ; Kyung Wan MIN ; Jeong Hyun PARK ; Sang Ah CHANG ; Bong Soo CHA ; Dong Jun KIM ; Yong Seong KIM ; Tae Keun OH ; Suk CHON ; Il Seong NAM-GOONG ; Mi Jin KIM ; Hye Soon KIM ; Young Sik CHOI ; You Hern AHN ; Sora LEE ; Sei Hyun BAIK
Diabetes & Metabolism Journal 2013;37(3):181-189
		                        		
		                        			
		                        			BACKGROUND: A1chieve(R) was a noninterventional study evaluating the clinical safety and efficacy of biphasic insulin aspart 30, insulin detemir, and insulin aspart. METHODS: Korean type 2 diabetes patients who have not been treated with the study insulin or have started it within 4 weeks before enrollment were eligible for the study. The patient selection and the choice of regimen were at the discretion of the physician. The safety and efficacy information was collected from the subjects at baseline, week 12, and week 24. The number of serious adverse drug reactions (SADRs) was the primary endpoint. The changes of clinical diabetic markers at week 12 and/or at week 24 compared to baseline were the secondary endpoints. RESULTS: Out of 4,058 exposed patients, 3,003 completed the study. During the study period, three SADRs were reported in three patients (0.1%). No major hypoglycemic episodes were observed and the rate of minor hypoglycemic episodes marginally decreased during 24 weeks (from 2.77 to 2.42 events per patient-year). The overall quality of life score improved (from 66.7+/-15.9 to 72.5+/-13.5) while the mean body weight was slightly increased (0.6+/-3.0 kg). The 24-week reductions in glycated hemoglobin, fasting plasma glucose and postprandial plasma glucose were 1.6%+/-2.2%, 2.5+/-4.7 mmol/L, and 4.0+/-6.4 mmol/L, respectively. CONCLUSION: The studied regimens showed improvements in glycemic control with low incidence of SADRs, including no incidence of major hypoglycemic episodes in Korean patients with type 2 diabetes.
		                        		
		                        		
		                        		
		                        			Biphasic Insulins
		                        			;
		                        		
		                        			Body Weight
		                        			;
		                        		
		                        			Diabetes Mellitus, Type 2
		                        			;
		                        		
		                        			Drug Toxicity
		                        			;
		                        		
		                        			Fasting
		                        			;
		                        		
		                        			Glucose
		                        			;
		                        		
		                        			Hemoglobins
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Insulin
		                        			;
		                        		
		                        			Insulin Aspart
		                        			;
		                        		
		                        			Insulin, Isophane
		                        			;
		                        		
		                        			Insulin, Long-Acting
		                        			;
		                        		
		                        			Patient Selection
		                        			;
		                        		
		                        			Plasma
		                        			;
		                        		
		                        			Quality of Life
		                        			;
		                        		
		                        			Republic of Korea
		                        			;
		                        		
		                        			Treatment Outcome
		                        			;
		                        		
		                        			Insulin Detemir
		                        			
		                        		
		                        	
8.Is there any vindication for low dose nonselective beta-blocker medication in patients with liver cirrhosis?.
Tae Wan KIM ; Hong Joo KIM ; Chang Uk CHON ; Hyun Sun WON ; Jung Ho PARK ; Dong Il PARK ; Yong Kyun CHO ; Chong Il SOHN ; Woo Kyu JEON ; Byung Ik KIM
Clinical and Molecular Hepatology 2012;18(2):203-212
		                        		
		                        			
		                        			BACKGROUND/AIMS: Nonselective beta-blockers (NSBBs), such as propranolol, reportedly exert a pleiotropic effect in liver cirrhosis. A previous report suggested that survival was higher in patients receiving adjusted doses of NSBBs than in ligation patients. This study investigated whether low-dose NSBB medication has beneficial effects in patients with liver cirrhosis, especially in terms of overall survival. METHODS: We retrospectively studied 273 cirrhotic patients (199 males; age 53.6+/-10.2 years, mean+/-SD) who visited our institution between March 2003 and December 2007; follow-up data were collected until June 2011. Among them, 138 patients were given a low-dose NSBB (BB group: propranolol, 20-60 mg/day), and the remaining 135 patients were not given an NSBB (NBB group). Both groups were stratified randomly according to Child-Turcotte-Pugh (CTP) classification and age. RESULTS: The causes of liver cirrhosis were alcohol (n=109, 39.9%), hepatitis B virus (n=125, 45.8%), hepatitis C virus (n=20, 7.3%), and cryptogenic (n=19, 7.0%). The CTP classes were distributed as follows: A, n=116, 42.5%; B, n=126, 46.2%; and C, n=31, 11.4%. Neither the overall survival (P=0.133) nor the hepatocellular carcinoma (HCC)-free survival (P=0.910) differed significantly between the BB and NBB groups [probability of overall survival at 4 years: 75.1% (95% CI=67.7-82.5%) and 81.2% (95% CI=74.4-88.0%), respectively; P=0.236]. In addition, the delta CTP score did not differ significantly between the two groups. CONCLUSIONS: Use of low-dose NSBB medication in patients with liver cirrhosis is not indicated in terms of overall and HCC-free survival.
		                        		
		                        		
		                        		
		                        			Adrenergic beta-Antagonists/*therapeutic use
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Alcohol Drinking
		                        			;
		                        		
		                        			Carcinoma, Hepatocellular/complications/diagnosis
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Follow-Up Studies
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Kaplan-Meier Estimate
		                        			;
		                        		
		                        			Kidney Failure, Chronic/complications/diagnosis
		                        			;
		                        		
		                        			Liver Cirrhosis/complications/*drug therapy/mortality
		                        			;
		                        		
		                        			Liver Neoplasms/complications/diagnosis
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Predictive Value of Tests
		                        			;
		                        		
		                        			Proportional Hazards Models
		                        			;
		                        		
		                        			Propranolol/*therapeutic use
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Severity of Illness Index
		                        			
		                        		
		                        	
9.The preconception stress and mental health of couples.
Yong Chon PARK ; Seon Cheol PARK ; Moon Il PARK
Journal of the Korean Medical Association 2011;54(8):832-837
		                        		
		                        			
		                        			The ultimate goal of the 'baby plan' is a healthy pregnancy and successful child rearing. Focusing on baby planning, this article covers issues concerning a successful and healthy pregnancy with a psychiatric point of view-the stress and mental health before the pregnancy. According to recent findings, stress influences a women's infertility rate 10 to 15 percent, and a major psychological reason is found to be depression rather than anxiety disorder. The infertility of men is also influenced by stress, based on the research findings that the density and quality of sperm worsens after disasters. Excessive stress before and during pregnancy could result in pre-term labor, small for gestational age infants, or reduced infant weight. In order to prevent these preconception distresses, psychiatric care and treatment are needed. In this regard, Eastern traditional wisdom could be helpful in the view of psychotherapy, since it has been traditionally approved and welcomed for more than a thousand years. One of the insights is that a sound relationship between a husband and wife is a foundation of a good family, and this has already been determined from the moment when the two met for the first time. In conclusion, preconception stress could negatively influence fertility and could have a negative effect on a pregnancy. Thus stress should be alieviated for a healthy pregnancy and successful child rearing by psychotherapeutic intervention.
		                        		
		                        		
		                        		
		                        			Anxiety Disorders
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Child Rearing
		                        			;
		                        		
		                        			Depression
		                        			;
		                        		
		                        			Disasters
		                        			;
		                        		
		                        			Family Characteristics
		                        			;
		                        		
		                        			Fertility
		                        			;
		                        		
		                        			Gestational Age
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Infant
		                        			;
		                        		
		                        			Infertility
		                        			;
		                        		
		                        			Mental Health
		                        			;
		                        		
		                        			Multiple Endocrine Neoplasia Type 1
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Psychotherapy
		                        			;
		                        		
		                        			Spermatozoa
		                        			;
		                        		
		                        			Spouses
		                        			
		                        		
		                        	
10.A Case of Rhabdomyolysis in a Body-Builder.
Hyung Soon PARK ; Sung Il JANG ; Yong Kyu LEE ; Hye Rim AN ; Hyung Chon PARK ; Sung Kyu HA ; Sung Jin MOON
Korean Journal of Nephrology 2009;28(4):335-338
		                        		
		                        			
		                        			Rhabdomyolysis is a serious and potentiallylethal disease that can develop from a variety of traumatic and nontraumatic conditions. In this report, the authors describe a case of rhabdomyolysis that occurredafter a body-building tournament. A 32-year-old body-builder was admitted due to quadriplegia and muscle pain. The patient had a serum potassium level of 1.8 mmol/L, creatinine phosphokinase level of 5,414 IU/L and urine myoglobin of 128.1 ng/ml. He had taken anabolic androgenic steroids for 6 months and overate himself with carbohydrate food after the tournament. Possible causes for the rhabdomyolysis were hypokalemia, exercise, and anabolic androgenic steroids, etc. His condition was fully recovered without complications after potassium replacement and general supportive care. Body- builders may be exposed to rhabdomyolysis risk factors such as diet control, weight reduction, and taking steroids. Therefore, special attention and education on rhabdomyolysis should be provided to body-builders.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Creatinine
		                        			;
		                        		
		                        			Diet
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypokalemia
		                        			;
		                        		
		                        			Muscles
		                        			;
		                        		
		                        			Myoglobin
		                        			;
		                        		
		                        			Potassium
		                        			;
		                        		
		                        			Quadriplegia
		                        			;
		                        		
		                        			Rhabdomyolysis
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Somatotypes
		                        			;
		                        		
		                        			Steroids
		                        			;
		                        		
		                        			Weight Loss
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail